Your browser doesn't support javascript.
loading
18F-Flortaucipir in TDP-43 associated frontotemporal dementia.
Smith, R; Santillo, A F; Waldö, M Landqvist; Strandberg, O; Berron, D; Vestberg, S; van Westen, D; van Swieten, J; Honer, M; Hansson, O.
Afiliação
  • Smith R; Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden. Ruben.Smith@med.lu.se.
  • Santillo AF; Department of Neurology, Skåne University Hospital, Lund, Sweden. Ruben.Smith@med.lu.se.
  • Waldö ML; Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
  • Strandberg O; Clinical Sciences Helsingborg, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden.
  • Berron D; Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
  • Vestberg S; Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
  • van Westen D; Department of Psychology, Lund University, Lund, Sweden.
  • van Swieten J; Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
  • Honer M; Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands.
  • Hansson O; Roche Pharmaceutical Research and Early Development, Neuroscience Translational Technologies, Roche Innovation Center, Basel, Switzerland.
Sci Rep ; 9(1): 6082, 2019 04 15.
Article em En | MEDLINE | ID: mdl-30988363
Retention of 18F-Flortaucipir is reportedly increased in the semantic variant of primary progressive aphasia (svPPA), which is dominated by TDP-43 pathology. However, it is unclear if 18F-Flortaucipir is also increased in other TDP-43 diseases, such as bvFTD caused by a C9orf72 gene mutation. We therefore recruited six C9orf72 expansion carriers, six svPPA patients, and 54 healthy controls. All underwent 18F-Flortaucipir PET and MRI scanning. Data from 39 Alzheimer's Disease patients were used for comparison. PET tracer retention was assessed both at the region-of-interest (ROI) and at the voxel-level. Further, autoradiography using 3H-Flortaucipir was performed. SvPPA patients exhibited higher 18F-Flortaucipir retention in the lateral temporal cortex bilaterally according to ROI- and voxel-based analyses. In C9orf72 patients, 18F-Flortaucipir binding was slightly increased in the inferior frontal lobes in the ROI based analysis, but these results were not replicated in the voxel-based analysis. Autoradiography did not show specific binding in svPPA cases or in C9orf72-mutation carriers. In conclusion, temporal lobe 18F-Flortaucipir retention was observed in some cases of svPPA, but the uptake was of a lower magnitude compared to AD dementia. C9orf72-mutation carriers exhibited none or limited 18F-Flortaucipir retention, indicating that 18F-Flortaucipir binding in TDP-43 proteinopathies is not a general TDP-43 related phenomenon.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lobo Temporal / Carbolinas / Proteínas tau / Proteínas de Ligação a DNA / Proteinopatias TDP-43 Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lobo Temporal / Carbolinas / Proteínas tau / Proteínas de Ligação a DNA / Proteinopatias TDP-43 Idioma: En Ano de publicação: 2019 Tipo de documento: Article